US Food and Drug Administration (US FDA) for its ANDA Norepinephrine Bitartrate Injection USP, 4 mg/4 mL (1 mg/mL) ...

Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the ...

Norepinephrine bitartrate injection is indicated to raise blood pressure in adult patients with acute hypotension.

This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.

Piramal Critical Care has reserved commercialisation rights for the EU, UK, and Norway and will look after Neoatricon in ...

Piramal Critical Care and BrePco Biopharma have secured UK approval for Neoatricon, a medication for low blood pressure and ...

Biocon Pharma Limited receives FDA approval for Norepinephrine Bitartrate Injection USP, expanding its complex drug portfolio ...

Developed by Ireland-based BrePco Biopharma, Neoatricon is the first paediatric-strength dopamine hydrochloride infusion for ...

Norepinephrine bitartrate injection is a critical medication used to raise blood pressure in adult patients suffering from ...

BrePco Biopharma Limited today announced that the UK Medicines and Healthcare products Regulatory Agency issued a grant of a ...

Bengaluru: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval ...